| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.3B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $6.46 | $5.28 | $7.49 | $0.79 | $3.02 | $1.67 | $0.76 | $0.45 |
| EPS (Diluted) | $6.26 | $5.09 | $7.32 | $0.77 | $2.87 | $1.65 | $0.75 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.9B | $22.3B | $21.3B | $20.9B | $19.6B | $18.4B | $11.5B | $9.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.4B | $3.8B | $3.8B | $0.5B | $0.5B | $0.7B | $0.2B | $0.1B |
| Total Liabilities | $22.8B | $20.5B | $19.7B | $19.5B | $18.2B | $17.3B | $10.5B | $8.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.1B | $1.8B | $1.6B | $1.4B | $1.4B | $1.1B | $1.1B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.1B | — | — | — | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-2.1B | $-1.0B | $3.2B | — | — | $-6.4B | $-1.4B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $2.2B | $0.8B | $0.1B | — | — | $6.8B | $1.5B | $-0.1B |